Australian Industry Rejects Planned Tendering System For Off-Patent Drugs
Executive Summary
Plans to introduce a tendering system for off-patent medicines have been sharply criticized by originator and generic industry bodies in Australia, but proposals for a fully operational electronic prescribing and health record system have met with a warmer reception.
You may also be interested in...
Stability At Last For Drug Innovators And Pricing In Australia
The Australian government has promised not to implement any new therapeutic groups under the Pharmaceutical Benefits Scheme for the next five years, nor will it introduce any new pricing reforms without consulting the innovative drug industry first.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.